The head of pharmaceutical giant Pfizer says the company is developing a vaccine that will specifically target the Omicron variant of Covid-19 and expects to have it available as soon as March.
Albert Bourla was speaking to US business network CNBC.
IN: "We are working…"
OUT: "…will be ready"
DUR: 26 seconds